CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market
Holding CGON?
Track your performance easily

CG Oncology, Inc. (CGON) Technical Analysis

98 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
0Bearish
CG Oncology, Inc.’s (CGON) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting CG Oncology, Inc. is a Sell.
CG Oncology, Inc.’s (CGON) 20-Day exponential moving average is 36.88, while CG Oncology, Inc.’s (CGON) share price is $39.94, making it a Buy.
CG Oncology, Inc.’s (CGON) 50-Day exponential moving average is 36.41, while CG Oncology, Inc.’s (CGON) share price is $39.94, making it a Buy.

CG Oncology, Inc. (CGON) Pivot Points

Nov 09, 2024, 12:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.47
35.61
37.15
38.29
39.83
40.97
42.51
Fibonacci
35.61
36.63
37.27
38.29
39.31
39.95
40.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CG Oncology, Inc. (CGON) Moving Averages

Nov 09, 2024, 12:54 PM
Period
Simple
Exponential
MA5
37.47Buy
37.85Buy
MA10
36.91Buy
37.25Buy
MA20
36.79Buy
36.88Buy
MA50
36.72Buy
36.41Buy
MA100
35.18Buy
36.21Buy
CG Oncology, Inc.’s (CGON) 10-Day exponential moving average is 37.25, while CG Oncology, Inc.’s (CGON) share price is $39.94, making it a Buy.
CG Oncology, Inc.’s (CGON) 100-Day exponential moving average is 36.21, while CG Oncology, Inc.’s (CGON) share price is $39.94, making it a Buy.
CG Oncology, Inc.’s (CGON) stock price is $39.94 and CG Oncology, Inc.’s (CGON) 50-day simple moving average is 36.72, creating a Buy signal.
CG Oncology, Inc.’s (CGON) stock price is $39.94 and CG Oncology, Inc.’s (CGON) 100-day simple moving average is 35.18, creating a Buy signal.

CG Oncology, Inc. (CGON) Technical Indicators

Nov 09, 2024, 12:54 PM
Name
Value
Implied Action
RSI (14)
62.96
Neutral
STOCH (9,6)
78.14
Neutral
STOCHRSI (14)
79.31
Neutral
MACD (12,26)
0.36
Sell
ADX (14)
10.55
Buy
Williams %R
-15.20
Sell
CCI (14)
256.50
Sell
ATR (14)
1.58
-
Ultimate Oscillator
58.62
Neutral
ROC
7.19
Buy
CG Oncology, Inc.’s (CGON) Relative Strength Index (RSI) is 62.96, creating a Neutral signal.
CG Oncology, Inc.’s (CGON) Trend Strength Indicator (ADX) is 10.55, creating a Buy signal.
CG Oncology, Inc.’s (CGON) Commodity Channel Index (CCI) is 256.50, creating a Sell signal.
CG Oncology, Inc.’s (CGON) Price Rate of Change (ROC) is 7.19, creating a Buy signal.

FAQ

Is CGON a Buy, Hold, or Sell?
Based on CGON’s technical indicators, CGON is a Buy.
    What is CGON’s RSI (14)?
    CGON’s RSI (14) is 62.96, which suggests CGON is a Neutral.
      What is CGON’s MACD?
      CGON’s MACD is 0.36, which suggests CGON is a Sell.
        What is CGON’s 5-day moving average?
        CGON’s 5-day moving average is 37.47, which suggests CGON is a Buy.
          What is CGON’s 20-day moving average?
          CGON 20-day moving average is 36.79, which suggests CGON is a Buy.
            What is CGON’s 50-day moving average?
            CGON’s 50-day moving average is 36.72, which suggests CGON is a Buy.
              What is CGON’s 200-day moving average?
              Currently, no data Available
              What is CGON’s Williams % R (14)?
              CGON’s Williams % R (14) is -15.20, which suggests CGON is a Sell.
                What is CGON’s CCI (14)?
                CGON’s CCI (14) is 256.50, which suggests CGON is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis